News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Jill Feldman: Dosing studies are critical!
Photo taken from Jill Feldman/LinkedIn
May 9, 2024, 14:30

Jill Feldman: Dosing studies are critical!

Jill Feldman, Co-Founder of EGFR Resisters, shared a post on X:

“Dosing studies are critical!
OS and QOL both matter and pts/fam are the ONLY ones who can choose what matters most to THEM Amgen Oncology (and many others) please consider alternate doses while doing further studies
PhRMA, please push MED (minimal effective), NOT MTD.”

Read further.
Source: Jill Feldman/X

Amgen Oncology cancer EGFR Resisters Jill Feldman OncoDaily Oncology PhRMA
Special Coverage
Blog
Jun 5, 2025, 02:37
Quita Beeler Highsmith Highlights Role of ASCO in Advancing Health Equity
Blog
Jun 5, 2025, 02:29
Sylvester Comprehensive Cancer Center Recaps ASCO 2025 Participation
Blog
Jun 5, 2025, 02:25
Gevorg Tamamyan: Wonderful Seeing Douglas Flora at ASCO25
Blog
Jun 5, 2025, 02:19
Childhood Cancer International Invites Survivors to Join Global SurNet Network
Blog
Jun 5, 2025, 02:12
Susanna Greer: How Our Researcher is Finding New Ways to Approach This Childhood Cancer
Blog
Jun 5, 2025, 02:05
Nazik Hammad Connects with African ASCO IDEA Award Recipients
Blog
Jun 5, 2025, 01:56
Runcie C.W. Chidebe Discusses HPV Vaccine Access and Innovation at ASCO
Insight
Jun 5, 2025, 01:54
Key Insights by Abner Antonio Murray from ASCO25
Science
Jun 5, 2025, 01:46
Stephen Liu: Proud to be Part of the Team Behind the Phase III IMforte trial
Blog
Jun 5, 2025, 01:36
Hedley Lewis: Reflecting on the St. Jude Global Alliance Sub-Saharan Africa Regional Meeting
Societies
Jun 4, 2025, 23:14
20 Posts Not to Miss from ASCO 2025
Career
Jun 4, 2025, 17:30
Fellowship and Short-Term Training Opportunities Now Open at POEM Training Centers - POEM Group